Related Experiment Videos
Pathogenesis of nasal polyps: an update.
Rafal Pawliczak1, Anna Lewandowska-Polak, Marek L Kowalski
1Department of Clinical Immunology and Allergy, Medical University of Lodz, 251 Pomorska Street, Building C5, Room 46, 92213 Lodz, Poland.
Current Allergy and Asthma Reports
|October 12, 2005
Summary
The exact cause of nasal polyps remains unknown, but activated epithelial cells and inflammatory mediators are key factors. Infectious agents may initiate this process, particularly in those with aspirin hypersensitivity rhinosinusitis/asthma syndrome.
Area of Science:
- Otorhinolaryngology
- Immunology
- Pathogenesis of sinonasal diseases
Background:
- The etiology of nasal polyps is not fully understood.
- Genetic factors are suspected but lack substantial supporting evidence.
- Activated epithelial cells are implicated as a primary source of mediators driving polyp formation.
Purpose of the Study:
- To explore the potential mechanisms and contributing factors in nasal polyp development.
- To investigate the role of epithelial cell activation, inflammation, and specific patient subgroups.
Main Methods:
- This study reviews current understanding and proposed mechanisms.
- Focuses on the role of inflammatory cells, fibroblasts, and infectious agents.
- Examines the significance of cytokines, growth factors, and arachidonic acid metabolites.
Main Results:
- Activated epithelial cells release mediators that attract inflammatory cells (e.g., eosinophils) and activate fibroblasts.
- Infectious agents (viruses, bacteria, fungi) are potential triggers for epithelial cell activation.
- Proinflammatory cytokines, growth factors, and arachidonic acid metabolites are crucial in persistent inflammation and polyp pathogenesis, especially in aspirin-exaggerated respiratory disease.
Conclusions:
- Nasal polyp formation involves a complex interplay of epithelial cell activation, inflammation, and fibroblast proliferation.
- Infectious agents and specific inflammatory mediators, particularly in aspirin-sensitive patients, are critical to the disease process.
- Further research is needed to elucidate the precise causal pathways and identify therapeutic targets.